| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |